• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用共价有机框架触发诱导三级淋巴样结构形成用于癌症免疫治疗

Trigger inducible tertiary lymphoid structure formation using covalent organic frameworks for cancer immunotherapy.

作者信息

Zhang Liang, Zhang Boxin, Zhang Meng-Jie, Li Wenlang, Li Hao, Jiao Yantian, Yang Qi-Chao, Wang Shuo, Liu Yuan-Tong, Song An, Feng Hai-Tao, Sun Jianwei, Kwok Ryan T K, Lam Jacky W Y, Tang Ben Zhong, Sun Zhi-Jun

机构信息

State Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, Key Laboratory of Oral Biomedicine Ministry of Education, Hubei Key Laboratory of Stomatology, School & Hospital of Stomatology, Frontier Science Center for Immunology and Metabolism, Taikang Center for Life and Medical Sciences, Wuhan University, Wuhan, China.

Division of Life Science and State Key Laboratory of Molecular Neuroscience, Department of Chemistry, The Hong Kong Branch of Chinese National Engineering Research Center for Tissue Restoration and Reconstruction, The Hong Kong University of Science and Technology, Clear Water Bay Kowloon, Hong Kong, China.

出版信息

Nat Commun. 2025 Jan 2;16(1):44. doi: 10.1038/s41467-024-55430-4.

DOI:10.1038/s41467-024-55430-4
PMID:39747845
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11696883/
Abstract

The discovery of tertiary lymphoid structures (TLS) within tumor tissues provides a promising avenue to promote the efficacy of cancer immunotherapy. Yet, the lack of effective strategies to induce TLS formation poses a substantial obstacle. Thus, the exploration of potential inducers for TLS formation is of great interest but remains challenging. Here, inspired by the mechanism of artificially cultivated pearls, a covalent organic framework (COF) is employed to induce TLS formation. Single-cell sequencing analysis reveals that this is achieved by promotion of cytokine hypersecretion, which facilitates the maturation, proliferation, and migration of T and B cells, critical for triggering TLS formation. Furthermore, the efficacy of COF-mediated phototherapy in inducing TLS formation is validated in both the MC38 and 4MOSC1 female tumor models. Notably, a strong synergistic effect between COF-mediated phototherapy and αCTLA-4 is observed, resulting in the effective eradication of both primary and distant tumors, while also inhibiting tumor recurrence.

摘要

肿瘤组织中三级淋巴结构(TLS)的发现为提高癌症免疫治疗的疗效提供了一条有前景的途径。然而,缺乏诱导TLS形成的有效策略构成了重大障碍。因此,探索TLS形成的潜在诱导剂备受关注,但仍具有挑战性。在此,受人工养殖珍珠机制的启发,采用共价有机框架(COF)来诱导TLS形成。单细胞测序分析表明,这是通过促进细胞因子的过度分泌来实现的,这有助于T细胞和B细胞的成熟、增殖和迁移,而这些对于触发TLS形成至关重要。此外,在MC38和4MOSC1雌性肿瘤模型中均验证了COF介导的光疗在诱导TLS形成方面的疗效。值得注意的是,观察到COF介导的光疗与αCTLA-4之间具有强烈的协同效应,从而有效根除原发性和远处肿瘤,同时还能抑制肿瘤复发。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edaa/11696883/fb09e6143133/41467_2024_55430_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edaa/11696883/d3f72e464a9f/41467_2024_55430_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edaa/11696883/dfc82c8bee3b/41467_2024_55430_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edaa/11696883/420a8e515f13/41467_2024_55430_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edaa/11696883/c3d75f140c0e/41467_2024_55430_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edaa/11696883/8db6f4fe7d38/41467_2024_55430_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edaa/11696883/e6218055292e/41467_2024_55430_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edaa/11696883/ff92d5de2ecc/41467_2024_55430_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edaa/11696883/24d583e1191c/41467_2024_55430_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edaa/11696883/fb09e6143133/41467_2024_55430_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edaa/11696883/d3f72e464a9f/41467_2024_55430_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edaa/11696883/dfc82c8bee3b/41467_2024_55430_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edaa/11696883/420a8e515f13/41467_2024_55430_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edaa/11696883/c3d75f140c0e/41467_2024_55430_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edaa/11696883/8db6f4fe7d38/41467_2024_55430_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edaa/11696883/e6218055292e/41467_2024_55430_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edaa/11696883/ff92d5de2ecc/41467_2024_55430_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edaa/11696883/24d583e1191c/41467_2024_55430_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edaa/11696883/fb09e6143133/41467_2024_55430_Fig9_HTML.jpg

相似文献

1
Trigger inducible tertiary lymphoid structure formation using covalent organic frameworks for cancer immunotherapy.利用共价有机框架触发诱导三级淋巴样结构形成用于癌症免疫治疗
Nat Commun. 2025 Jan 2;16(1):44. doi: 10.1038/s41467-024-55430-4.
2
Immune mechanisms orchestrate tertiary lymphoid structures in tumors via cancer-associated fibroblasts.免疫机制通过癌症相关成纤维细胞调控肿瘤中的三级淋巴结构。
Cell Rep. 2021 Jul 20;36(3):109422. doi: 10.1016/j.celrep.2021.109422.
3
Mature tertiary lymphoid structures: important contributors to anti-tumor immune efficacy.成熟的三级淋巴样结构:抗肿瘤免疫疗效的重要贡献者。
Front Immunol. 2024 Jul 4;15:1413067. doi: 10.3389/fimmu.2024.1413067. eCollection 2024.
4
Targeting Tertiary Lymphoid Structures for Tumor Immunotherapy.靶向三级淋巴结构进行肿瘤免疫治疗。
Methods Mol Biol. 2018;1845:275-286. doi: 10.1007/978-1-4939-8709-2_16.
5
STINGing the Tumor Microenvironment to Promote Therapeutic Tertiary Lymphoid Structure Development.STING 靶向肿瘤微环境以促进治疗性三级淋巴结构的形成。
Front Immunol. 2021 May 13;12:690105. doi: 10.3389/fimmu.2021.690105. eCollection 2021.
6
STING agonist-based treatment promotes vascular normalization and tertiary lymphoid structure formation in the therapeutic melanoma microenvironment.基于 STING 激动剂的治疗促进了治疗性黑色素瘤微环境中的血管正常化和三级淋巴结构形成。
J Immunother Cancer. 2021 Feb;9(2). doi: 10.1136/jitc-2020-001906.
7
Tertiary Lymphoid Structures and B cells: Clinical impact and therapeutic modulation in cancer.三级淋巴结构与 B 细胞:癌症中的临床影响与治疗调控。
Semin Immunol. 2020 Apr;48:101406. doi: 10.1016/j.smim.2020.101406. Epub 2020 Nov 25.
8
Oncolytic herpes simplex virus propagates tertiary lymphoid structure formation via CXCL10/CXCR3 to boost antitumor immunity.溶瘤单纯疱疹病毒通过CXCL10/CXCR3促进三级淋巴结构形成,以增强抗肿瘤免疫力。
Cell Prolif. 2025 Jan;58(1):e13740. doi: 10.1111/cpr.13740. Epub 2024 Sep 1.
9
Tertiary Lymphoid Structure-Associated B Cells Enhance CXCL13CD103CD8 Tissue-Resident Memory T-Cell Response to Programmed Cell Death Protein 1 Blockade in Cancer Immunotherapy.三级淋巴结构相关 B 细胞增强了趋化因子 CXCL13+CD103+CD8+组织驻留记忆 T 细胞对癌症免疫治疗中程序性细胞死亡蛋白 1 阻断的反应。
Gastroenterology. 2024 Jun;166(6):1069-1084. doi: 10.1053/j.gastro.2023.10.022. Epub 2023 Oct 29.
10
Tertiary lymphoid structures in anticancer immunity.肿瘤免疫中的三级淋巴结构
Nat Rev Cancer. 2024 Sep;24(9):629-646. doi: 10.1038/s41568-024-00728-0. Epub 2024 Aug 8.

引用本文的文献

1
Bispecific antibody targeting CD155 mediates T-cell immunotherapy against human gynecological malignancies.靶向CD155的双特异性抗体介导针对人类妇科恶性肿瘤的T细胞免疫疗法。
Invest New Drugs. 2025 Apr;43(2):318-327. doi: 10.1007/s10637-025-01529-4. Epub 2025 Apr 15.

本文引用的文献

1
Mesoporous silica/organosilica nanoparticles for cancer immunotherapy.用于癌症免疫治疗的介孔二氧化硅/有机硅纳米粒子
Exploration (Beijing). 2023 May 9;3(3):20220086. doi: 10.1002/EXP.20220086. eCollection 2023 Jun.
2
More Is Better: Dual-Acceptor Engineering for Constructing Second Near-Infrared Aggregation-Induced Emission Luminogens to Boost Multimodal Phototheranostics.多多益善:双受体工程构建第二代近红外聚集诱导发光材料以增强多模式光热治疗。
J Am Chem Soc. 2023 Oct 18;145(41):22776-22787. doi: 10.1021/jacs.3c08627. Epub 2023 Oct 9.
3
Stem-like CD4 T cells in perivascular tertiary lymphoid structures sustain autoimmune vasculitis.
血管周围三级淋巴结构中的类干细胞 CD4 T 细胞维持自身免疫性血管炎。
Sci Transl Med. 2023 Sep 6;15(712):eadh0380. doi: 10.1126/scitranslmed.adh0380.
4
Integration of AIEgens into covalent organic frameworks for pyroptosis and ferroptosis primed cancer immunotherapy.将 AIEgens 整合到共价有机框架中,用于预先引发细胞焦亡和铁死亡的癌症免疫治疗。
Nat Commun. 2023 Sep 2;14(1):5355. doi: 10.1038/s41467-023-41121-z.
5
Activation of Pyroptosis Using AIEgen-Based sp Carbon-Linked Covalent Organic Frameworks.基于聚集诱导发光体的 sp3 碳连接共价有机框架激活细胞焦亡。
J Am Chem Soc. 2023 Aug 16;145(32):17689-17699. doi: 10.1021/jacs.3c04027. Epub 2023 Aug 7.
6
AIEgen-Based Covalent Organic Frameworks for Preventing Malignant Ventricular Arrhythmias Via Local Hyperthermia Therapy.基于聚集诱导发光(AIE)分子的共价有机框架用于通过局部热疗预防恶性室性心律失常
Adv Mater. 2023 Aug 2:e2304620. doi: 10.1002/adma.202304620.
7
Engineering metal-based hydrogel-mediated tertiary lymphoid structure formation activation of the STING pathway for enhanced immunotherapy.工程金属基水凝胶介导的三级淋巴结构形成 STING 通路的激活增强免疫治疗。
Mater Horiz. 2023 Oct 2;10(10):4365-4379. doi: 10.1039/d3mh00748k.
8
Adjuvant lipidoid-substituted lipid nanoparticles augment the immunogenicity of SARS-CoV-2 mRNA vaccines.佐剂脂质纳米颗粒增强了 SARS-CoV-2 mRNA 疫苗的免疫原性。
Nat Nanotechnol. 2023 Sep;18(9):1105-1114. doi: 10.1038/s41565-023-01404-4. Epub 2023 Jun 26.
9
Localized nuclear reaction breaks boron drug capsules loaded with immune adjuvants for cancer immunotherapy.局部核反应打破了装载免疫佐剂的硼药物胶囊,用于癌症免疫治疗。
Nat Commun. 2023 Apr 5;14(1):1884. doi: 10.1038/s41467-023-37253-x.
10
Reticular Chemistry-Enabled Sonodynamic Activity of Covalent Organic Frameworks for Nanodynamic Cancer Therapy.网状化学增强共价有机框架的声动力学活性用于纳米动力癌症治疗。
Angew Chem Int Ed Engl. 2023 May 8;62(20):e202302146. doi: 10.1002/anie.202302146. Epub 2023 Apr 3.